Open-label Adjunctive Zonisamide for Bipolar Disorder

Clinical trial NCT00047567 · TERMINATED

Trial details

NCT number: NCT00047567
Sponsor: Elan Pharmaceuticals
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Bipolar Disorders

Start date: 2002-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.